Rationale and design of the Transcatheter Aortic Valve Replacement to UNload the Left ventricle in patients with ADvanced heart failure (TAVR UNLOAD)

Slides:

Advertisements

Similar presentations

Low-Dose Aspirin in Patients with Stable Cardiovascular Disease: A Meta-analysis Jeffrey S. Berger, MD, MS, David L. Brown, MD, Richard C. Becker, MD The.

Advertisements

How surgeons can find information online? Martin Hewitt International Journal of Surgery Volume 5, Issue 6, Pages (December 2007) DOI: /j.ijsu

Tubular heart valves: A new tissue prosthesis design—Preclinical evaluation of the 3F aortic bioprosthesis James L. Cox, MD, Niv Ad, MD, Keith Myers, BS,

Overview of the 2012 Food and Drug Administration Circulatory System Devices Panel of the Medical Devices Advisory Committee meeting on the Edwards SAPIEN.

Balloon aortic valvuloplasty in the era of transcatheter aortic valve replacement: Acute and long-term outcomes Hélène Eltchaninoff, MD, Eric Durand,

Volume 385, Issue 9986, Pages (June 2015)

Volume 387, Issue 10034, Pages (May 2016)

Meta-Analysis of Transcatheter Aortic Valve Replacement Versus Surgical Aortic Valve Replacement in Patients With Severe Aortic Valve Stenosis Ashok.

Rationale and design of the PRAETORIAN trial: A Prospective, RAndomizEd comparison of subcuTaneOus and tRansvenous ImplANtable cardioverter-defibrillator.

Rationale and design of the Fractional Flow Reserve versus Angiography for Multivessel Evaluation (FAME) 3 Trial: A comparison of fractional flow reserve–guided.

American Heart Journal

A critical review of hemodynamic changes and left ventricular remodeling after surgical aortic valve replacement and percutaneous aortic valve replacement

Infective endocarditis in patients receiving chronic hemodialysis: A 21-year observational cohort study in Denmark Lene Ugilt Pagter Ludvigsen, MD, Lars.

Hypertension-Lipid Connection: Introduction

Rationale and design of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist Trial: A randomized, controlled study.

Impact of weight reduction on pericardial adipose tissue and cardiac structure in patients with atrial fibrillation Hany S. Abed, BPharm, MBBS, PhD,

Platelet function monitoring in elderly patients on prasugrel after stenting for an acute coronary syndrome: Design of the randomized antarctic study

Automatic Optimization of Cardiac Resynchronization Therapy Using SonR—Rationale and Design of the Clinical Trial of the SonRtip Lead and Automatic AV-VV.

A comparison of dabigatran etexilate with warfarin in patients with mechanical heart valves: The Randomized, phase II study to Evaluate the sAfety and.

New-onset Atrial Fibrillation Predicts Heart Failure Progression

Evaluating the safety and efficacy of sodium-restricted/Dietary Approaches to Stop Hypertension diet after acute decompensated heart failure hospitalization:

Transcatheter aortic valve replacement in patients with severe aortic stenosis who are at high risk for surgical complications: Summary assessment of.

Max B. Mitchell, MD The Journal of Thoracic and Cardiovascular Surgery

Of mice and men and surgical transcatheter aortic valve insertion

Manuel J. Antunes, MD, PhD, DSc

Ajay J. Kirtane, MD, SM, Warren J. Manning, MD

Rationale and design of a randomized clinical trial to assess the safety and efficacy of frequent optimization of cardiac resynchronization therapy: The.

Aortic valve replacement in low-flow, low-gradient aortic stenosis: Left ventricular ejection fraction matters Victor Dayan, MD, PhD, Philippe Pibarot,

Contribution of Three-Dimensional Transesophageal Echocardiography to Diagnosis and Management of Thrombosis of a St. Jude Mechanical Prosthesis in the.

Sexuality The American Journal of Medicine

Transcatheter Aortic Valve Implantation: A Canadian Cardiovascular Society Position Statement John Webb, MD, FRCPC, Josep Rodés-Cabau, MD, FRCPC, Stephen.

Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Prior Coronary Artery Bypass Graft Operation: A PARTNER Trial Subgroup Analysis

Paul J. Chai, MD, Isaac George, MD, Tamim M. Nazif, MD, FACC, David M

Aborted episode of sudden death due to delayed heart block after transcatheter aortic valve insertion Kevin L. Greason, MD, Paul A. Friedman, MD, Daniel.

Synovial neurofibromatosis in von Recklinghausen’s disease

Trends in Comorbidity, Disability, and Polypharmacy in Heart Failure

Emergency use of cardiopulmonary bypass in complicated transcatheter aortic valve replacement: Importance of a heart team approach Eric E. Roselli, MD,

A comprehensive review of the PARTNER trial

The American Association for Thoracic Surgery 2016 Ethics Forum: Cost-effectiveness and the ethics of left ventricular assist device therapy John W.C.

Epidemiology of Myelodysplastic Syndromes

Management of Patients With Aortic Valve Stenosis

Ruben L. J. Osnabrugge, MSc, Stuart J. Head, MSc, Tessa S. S

The DRESS Syndrome: A Literature Review

History of Thyroid Disorders in Relation to Clinical Outcomes in Atrial Fibrillation Helene Bruere, MD, Laurent Fauchier, MD, PhD, Anne Bernard Brunet,

Gout in African Americans

The relative performance characteristics of the logistic European System for Cardiac Operative Risk Evaluation score and the Society of Thoracic Surgeons.

William M. DeCampli, MD, PhD

Updated standardized endpoint definitions for transcatheter aortic valve implantation: The Valve Academic Research Consortium-2 consensus document∗ A.

Quadruple valve replacement in patients with carcinoid heart disease

Myocardial Injury After Transaortic Versus Transapical Transcatheter Aortic Valve Replacement Henrique B. Ribeiro, MD, Abdellaziz Dahou, MD, Marina Urena,

Risk-corrected impact of mechanical versus bioprosthetic valves on long-term mortality after aortic valve replacement Ole Lund, MD, PhD, Martin Bland,

Transcatheter aortic valve replacement in intermediate-risk patients

Michele Gallo, MD, Gino Gerosa, MD

Age alone should not preclude surgery: Contemporary outcomes after aortic valve replacement in nonagenarians Isaac George, MD, Halit Yerebakan, MD, Bindu.

Does Methylphenidate Reduce the Symptoms of Chronic Fatigue Syndrome?

Jonathan D. Kirsch, MD, Alisa Duran, MD, Alexander M

Outcomes of Transcatheter and Surgical Aortic Valve Replacement in Patients on Maintenance Dialysis Fahad Alqahtani, MD, Sami Aljohani, MD, Khaled Boobes,

Transcatheter aortic valve replacement and surgical aortic valve replacement: Both excellent therapies J. James Edelman, MBBS(Hons), PhD, Vinod H. Thourani,

Fenton H. McCarthy, MD, MS, Nimesh D. Desai, MD, PhD

A Post-cure Complication

Commentary: Bioprosthetic aortic valve replacement: A high standard of comparison for transcatheter aortic valve implantation Aaron Martin, MD, Michael.

Transcatheter aortic valve replacement for prime time unrestricted distribution? Not so fast, my friend G. Michael Deeb, MD, John Carroll, MD The Journal.

Rebecca D. Chason, Joan S. Reisch, PhD, Don C. Rockey, MD

Decongestive Treatment of Acute Decompensated Heart Failure: Cardiorenal Implications of Ultrafiltration and Diuretics Benjamin J. Freda, DO, Mara Slawsky,

Permanent pacemaker insertion following transcatheter aortic valve replacement: Not infrequent, not benign, and becoming predictable Craig M. Jarrett,

Commentary: When a choice is not an echo

Racing to the Rubicon Michael J. Reardon, MD, Vinod H. Thourani, MD

Avoiding coronary obstruction after transcatheter aortic valve replacement: Is it the skirt or what's inside that counts? Mohamad Alkhouli, MD, Vinay.

Has mortality from acute renal failure decreased

Paul Philipp Heinisch, MD, Thierry Carrel, MD

Presentation transcript:

Rationale and design of the Transcatheter Aortic Valve Replacement to UNload the Left ventricle in patients with ADvanced heart failure (TAVR UNLOAD) trial Ernest Spitzer, MD, Nicolas M. Van Mieghem, MD, PhD, Philippe Pibarot, DVM, Rebecca T. Hahn, MD, Susheel Kodali, MD, Mathew S. Maurer, MD, Tamim M. Nazif, MD, Josep Rodés-Cabau, MD, Jean-Michel Paradis, MD, Arie-Pieter Kappetein, MD, PhD, Ori Ben- Yehuda, MD, Gerrit-Anne van Es, PhD, Faouzi Kallel, PhD, William N. Anderson, PhD, Jan Tijssen, PhD, Martin B. Leon, MD American Heart Journal Volume 182, Pages 80-88 (December 2016) DOI: 10.1016/j.ahj.2016.08.009 Copyright © 2016 Elsevier Inc. Terms and Conditions

Figure 1 Pathophysiologic rationale for the TAVR UNLOAD trial. American Heart Journal 2016 182, 80-88DOI: (10.1016/j.ahj.2016.08.009) Copyright © 2016 Elsevier Inc. Terms and Conditions

Figure 2 Study flow-chart of the TAVR UNLOAD trial. American Heart Journal 2016 182, 80-88DOI: (10.1016/j.ahj.2016.08.009) Copyright © 2016 Elsevier Inc. Terms and Conditions